Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Phase 1/2 Terminated 2 enrolled GlycoMimetics Incorporated University of Michigan · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the safety profile of GMI-1271 and its effect on thrombus resolution in patients with distal calf vein Deep Venous Thrombosis (DVT).

Timeline

Start: 2016-07
Primary completion: 2016-11
Completion: 2016-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Enoxaparin sodium	Other / unclassified	—	—
Subject	Uproleselan	Small molecule	—	—

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Summary

Timeline

Drugs

Indications